United States · FDA National Drug Code directory
Klisyri
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16110-391_f94fb2ea-6246-4279-8819-f9b6d038e47c
- Product NDC
- 16110-391
- Form
- OINTMENT
- Composition / generic term
- tirbanibulin
- Labeler
- Almirall, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20201214
- Source listing expiry
- 20271231
Source-listed ingredients
- TIRBANIBULIN — 10 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 5 PACKET in 1 CARTON (16110-391-05) / .25 g in 1 PACKET · 16110-391-05
- 5 PACKET in 1 CARTON (16110-391-55) / .35 g in 1 PACKET · 16110-391-55
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →